Author:
Rezaee Aryan,Tehrany Pooya M.,Tirabadi Farimah Jafari,Sanadgol Negin,Karimi Asal Sadat,Ajdari Atra,Eydivandi Sepideh,Etemad Sara,Rajabi Romina,Rahmanian Parham,Khorrami Ramin,Nabavi Noushin,Aref Amir Reza,Fan Xiaoping,Zou Rongjun,Rashidi Mohsen,Zandieh Mohammad Arad,Hushmandi Kiavash
Subject
Pharmacology,General Medicine
Reference238 articles.
1. C.L. Moody, R.T.J.P. Wheelhouse, Med. Chem. imidazotetrazine prodrugs 7 2014 797 838.
2. J.M. Reid, D.C. Stevens, J. Rubin, M.M.J.Ccr Ames, Pharmacokinet. 3-methyl-(triazen-1-Yl. ) imidazole-4-carboximide Adm. temozolomide Patients Adv. Cancer 3 1997 2393 2398.
3. Temozolomide resistance in glioblastoma multiforme;Lee;Genes Dis.,2016
4. M.R. Middleton, J. Grob, N. Aaronson, G. Fierlbeck, W. Tilgen, S. Seiter, M. Gore S. Aamdal J. Cebon A.J.Jo.C.O. Coates Random phase III Study temozolomide Versus dacarbazine Treat. Patients Adv. metastatic Malig. Melanoma 18 2000.158-158.
5. I. Quirt, S. Verma, T. Petrella, K. Bak, M.J.To Charette, Temozolomide for the treatment of metastatic melanoma: a systematic review 12 2007 1114 1123.
Cited by
4 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献